abstract gray background

Archives: Resources

PPD | Infographic
The 2025 State of FSP Outsourcing: Challenges, Trends and Opportunities, and the Future of FSP Strategies and Models
  • External Link

Discover how FSP and hybrid FSP/FSO models are helping sponsors better navigate clinical development outsourcing.

Read More
PPD | Overview
Real-world evidence studies – Diverse Data Designs
  • PDF (76.13 KB)

In close collaboration with sponsors, we identify and understand multi-stakeholder evidence needs across the product lifecycle.

Read overview
PPD | Overview
US inflation reduction act: pipeline considerations
  • PDF (47.74 KB)

A risk exposure framework for drug developers.

Read the overview
PPD | Overview
Navigate the EU HTA Regulation
  • PDF (114.87 KB)

Trusted partner with 30+ years of experience in EU HTA, aiding health tech developers through EU HTA Regulation complexities.

Read the overview
PPD | Overview
Registries and Real-world Evidence
  • PDF (71.05 KB)

Customizable registry solutions for actionable insights, tailored study design, and regulatory-grade data to accelerate development.

Read the overview
PPD | Overview
Peri- and Post-approval Safety and Real-world Insights
  • PDF (56.64 KB)

Learn how we optimize post-authorization safety obligations with a holistic, collaborative, and custom study design approach.

Read the overview
PPD | Overview
Pregnancy Safety Studies
  • PDF (67.18 KB)
Read More
PPD | White Paper
Advancing Rare Disease Treatments in the COVID-19 Era and Beyond
  • External Link

Read our white paper on the continued interest in developing treatments for rare diseases.

Get the white paper
PPD | Resource
Pediatric Drug Development: Trends in the EU
  • External Link

A discussion on Pediatric Investigation Plans (PIPs), a 10-year report on the impact of the Regulation, and pediatric clinical trials.

Get the white paper